These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5029101)

  • 1. [The risk of hypoglycemia in sulfonylurea therapy].
    Berger W; Koller F
    Helv Med Acta; 1972 Apr; 36(2):228-9. PubMed ID: 5029101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Oral therapy in diabetes mellitus.
    Scoville AB
    South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
    [No Abstract]   [Full Text] [Related]  

  • 4. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
    Berger W
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral antidiabetics].
    Bäbler M
    Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications in the therapy of diabetes using oral hypoglycemic agents].
    De Luca E; Pellegrini M
    Minerva Med; 1974 Dec; 65(90):4769-71. PubMed ID: 4449610
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
    Cheah JS
    Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril.
    Rett K; Wicklmayr M; Dietze GJ
    N Engl J Med; 1988 Dec; 319(24):1609. PubMed ID: 3059189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse effects and interactions of oral antidiabetics].
    Czyzyk A; Stryjek-Kamińska D
    Pol Tyg Lek; 1980 Nov; 35(45):1757-60. PubMed ID: 7012809
    [No Abstract]   [Full Text] [Related]  

  • 10. [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
    Berger W; Caduff F; Pasquel M; Rump A
    Schweiz Med Wochenschr; 1986 Feb; 116(5):145-51. PubMed ID: 3961464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes therapy in adults].
    Berger M; Gries FA
    Med Welt; 1975 Oct; 26(42):1914-8. PubMed ID: 1186480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
    Hasslacher C; Wahl P
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus--refractory obesity.
    Br Med J; 1972 Jul; 3(5819):163-5. PubMed ID: 5064737
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M; Langhan T; Prosser J; Hoffman R
    Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutical principles and drug therapy of diabetes in adults].
    Constam GR
    Med Welt; 1975 Oct; 26(40):1837-42. PubMed ID: 1186478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of senile diabetes].
    Bertolini AM; Emanueli A; Sacchetti G; Santagostino A
    Minerva Med; 1975 May; 66(34):1605-7. PubMed ID: 1128807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.
    Borst GC
    J Ky Med Assoc; 1988 Mar; 86(3):129-30. PubMed ID: 3356924
    [No Abstract]   [Full Text] [Related]  

  • 20. [Speech disorders--disorientation--hemiparesis].
    Sander U
    Fortschr Med; 1982 Jul; 100(26):1262-4. PubMed ID: 7118035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.